James Malone

1.8k total citations
34 papers, 1.5k citations indexed

About

James Malone is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, James Malone has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in James Malone's work include Diabetes Management and Research (30 papers), Diabetes Treatment and Management (22 papers) and Metabolism, Diabetes, and Cancer (9 papers). James Malone is often cited by papers focused on Diabetes Management and Research (30 papers), Diabetes Treatment and Management (22 papers) and Metabolism, Diabetes, and Cancer (9 papers). James Malone collaborates with scholars based in United States, Netherlands and Italy. James Malone's co-authors include Barbara N. Campaigne, Patricia A. Cleary, William T. Dahms, Neil H. White, W. V. Tamborlane, David E. Goldstein, Byron J. Hoogwerf, Leigh MacConell, Richard Sachson and John H. Holcombe and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

James Malone

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Malone United States	17	1.3k	499	307	296	125	34	1.5k
Tabitha Randell United Kingdom	19	773 0.6×	422 0.8×	117 0.4×	394 1.3×	138 1.1×	53	1.1k
Claudia Brufani Italy	19	403 0.3×	283 0.6×	171 0.6×	172 0.6×	124 1.0×	36	888
H Hanaire-Broutin France	20	1.1k 0.8×	574 1.2×	136 0.4×	454 1.5×	104 0.8×	37	1.4k
Ian Lawrence United Kingdom	15	496 0.4×	206 0.4×	64 0.2×	197 0.7×	122 1.0×	31	787
P. Gerry Fegan Australia	13	338 0.3×	104 0.2×	76 0.2×	59 0.2×	72 0.6×	47	610
Hanna Dis Margeirsdottir Norway	14	509 0.4×	154 0.3×	36 0.1×	222 0.8×	83 0.7×	25	763
P.G. McNally United Kingdom	15	328 0.3×	175 0.4×	38 0.1×	167 0.6×	52 0.4×	28	595
D J Becker United States	8	679 0.5×	219 0.4×	66 0.2×	283 1.0×	91 0.7×	12	1.0k
Kristina Johnsson Sweden	14	747 0.6×	330 0.7×	368 1.2×	24 0.1×	36 0.3×	21	919
Claudia Piona Italy	16	357 0.3×	243 0.5×	22 0.1×	212 0.7×	65 0.5×	59	569

Countries citing papers authored by James Malone

Since Specialization

Citations

This map shows the geographic impact of James Malone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Malone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Malone more than expected).

Fields of papers citing papers by James Malone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Malone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Malone. The network helps show where James Malone may publish in the future.

Co-authorship network of co-authors of James Malone

This figure shows the co-authorship network connecting the top 25 collaborators of James Malone. A scholar is included among the top collaborators of James Malone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Malone. James Malone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tillman, John B., Roy W. Beck, William H. Polonsky, et al.. (2024). Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis. The Journal of Clinical Endocrinology & Metabolism. 110(8). 2134–2146. 1 indexed citations

Tillman, John B., et al.. (2023). First Real-World Experience With Bigfoot Unity: A 6-Month Retrospective Analysis. Clinical Diabetes. 41(4). 539–548. 11 indexed citations

Malone, James, et al.. (2023). 936-P: Three-Month Interim Analysis from the Prospective Bigfoot Unity Real World Study (BURST). Diabetes. 72(Supplement_1). 2 indexed citations

Grunberger, George, Anuj Bhargava, Trang T. Ly, et al.. (2018). Human Regular U-500 Insulin via Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Adults with T2D—The VIVID Study, Primary Population. Diabetes. 67(Supplement_1). 2 indexed citations

Hudson, Lynn D., Rebecca Kush, Bárbara Jaúregui, et al.. (2018). Global Standards to Expedite Learning From Medical Research Data. Clinical and Translational Science. 11(4). 342–344. 6 indexed citations

Ma, Xiaosu, Jenny Y. Chien, Jennal Johnson, James Malone, & Vikram Sinha. (2017). Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications. Diabetes Technology & Therapeutics. 19(8). 483–490. 2 indexed citations

Pencek, Richard, Steven C. Brunell, Yan Li, Byron J. Hoogwerf, & James Malone. (2012). Exenatide Once Weekly for the Treatment of Type 2 Diabetes Mellitus: Clinical Results in Subgroups of Patients Using Different Concomitant Medications. Postgraduate Medicine. 124(4). 33–40. 13 indexed citations

Pencek, Richard, Steven C. Brunell, Yan Li, Byron J. Hoogwerf, & James Malone. (2012). Use of Concomitant Glucose-Lowering Therapies and Associated Treatment Results Observed in Clinical Trials of Twice-Daily Exenatide. Endocrine Practice. 18(2). 227–237. 12 indexed citations

Malone, James, et al.. (2011). The physiological effects of low-intensity neuromuscular electrical stimulation (NMES) on short-term recovery from supra-maximal exercise bouts in male triathletes. European Journal of Applied Physiology. 112(7). 2421–2432. 17 indexed citations

10.

Wysham, Carol, Richard M. Bergenstal, Jaret Malloy, et al.. (2011). DURATION‐2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once‐weekly exenatide. Diabetic Medicine. 28(6). 705–714. 101 indexed citations

11.

Gill, Anne, Byron J. Hoogwerf, Simon Bruce, et al.. (2010). Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study. Cardiovascular Diabetology. 9(1). 6–6. 117 indexed citations

12.

Malone, James, Michael Trautmann, Ken Wilhelm, Kristin Taylor, & David M. Kendall. (2009). Exenatide once weekly for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs. 18(3). 359–367. 37 indexed citations

13.

Ilag, Liza L., Lisa Kerr, James Malone, & Meng H. Tan. (2007). Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison. Clinical Therapeutics. 29(6). 1254–1270. 72 indexed citations

14.

Roach, Paris & James Malone. (2006). Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24‐h standardized test‐meal period in patients with Type 2 diabetes. Diabetic Medicine. 23(7). 743–749. 16 indexed citations

15.

Ceriello, Antonio, Stefano Del Prato, Juliana Bue‐Valleskey, et al.. (2006). Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors. Journal of Diabetes and its Complications. 21(1). 20–27. 14 indexed citations

16.

Malone, James, Shuang Bai, Barbara N. Campaigne, Jesús Reviriego, & B. Augendre‐Ferrante. (2005). Twice‐daily pre‐mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabetic Medicine. 22(4). 374–381. 118 indexed citations

17.

Malone, James, et al.. (2004). Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clinical Therapeutics. 26(12). 2034–2044. 146 indexed citations

18.

Malone, James, et al.. (2003). Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?. Diabetes Research and Clinical Practice. 62(3). 187–195. 20 indexed citations

19.

Mattoo, Vinod, Zvonko Miličević, James Malone, et al.. (2003). A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Research and Clinical Practice. 59(2). 137–143. 68 indexed citations

20.

Malone, James, James R. Woodworth, Vipin Arora, et al.. (2000). Improved postprandial glycemic control with humalog® mix75/25™ after a standard test meal in patients with type 2 diabetes mellitus. Clinical Therapeutics. 22(2). 222–230. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact